Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting

INTRODUCTION: In routine clinical care, important treatment outcomes among patients with moderate-to-severe plaque psoriasis (PsO) have been shown to vary according to patient demographics and disease characteristics. This study aimed to provide direct comparative effectiveness data at week 12 betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynde, Charles, Riedl, Elisabeth, Maul, Julia-Tatjana, Torres, Tiago, Pinter, Andreas, Fabbrocini, Gabrielle, Daniele, Flavia, Brnabic, Alan, Reed, Catherine, Wilhelm, Stefan, Holzkämper, Thorsten, Schuster, Christopher, Puig, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988734/
https://www.ncbi.nlm.nih.gov/pubmed/36515803
http://dx.doi.org/10.1007/s12325-022-02379-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988734/
https://www.ncbi.nlm.nih.gov/pubmed/36515803
http://dx.doi.org/10.1007/s12325-022-02379-9

Ejemplares similares